EFFECTS OF NUTRIENTS IN HYPERTENSION
EFFECTS OF NUTRIENTS IN HYPERTENSION
批准号:
2218631
负责人:
ROSE M ROBERTSON
金额:
$13.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-04-01 至 1995-03-31
关键词:
adrenergic agents aldosterone angiotensin /renin /aldosterone hypertension blood pressure body fluids calcium metabolism catecholamines diet therapy dietary calcium dietary mineral dietary sodium dietary supplements electrolyte balance hormone regulation /control mechanism human subject hypertension magnesium mathematical model nutrition related tag parathyroid hormones renin salt intake vascular resistance vitamin D
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This supplemental application requests support for the completion of a
nutritional study of the effects and interactions of dietary calcium and
sodium in patients with essential hypertension. The underlying hypothesis
of this study is that dietary calcium supplementation can lower blood
pressure in essential hypertension. While there is epidemiologic data
suggesting that the level of calcium intake can influence blood pressure,
this data and its interpretation are controversial. In addition, the
extent of the effect of calcium (if present) and its mechanism(s) are
uncertain. It has been suggested that the variability in the available
data may be due to differential effects of dietary manipulation in subsets
of the hypertensive population. Because it was clear that more information
was needed before general dietary recommendations were considered,
proposals addressing these issues were invited and the current study
funded.
These ongoing investigations are based on the careful characterization of
mild-to-moderate essential hypertensives as to salt-sensitivity and renin
status. Methods include determination of systolic and diastolic blood
pressure, supine and upright (random-zero technique), studies of
electrolyte and fluid balance, assessment of forearm vascular reactivity to
adrenergic agonists, studies of platelet function and intracellular
electrolytes. Circulating calcium and sodium levels, renin, aldosterone,
catecholamines, parathyroid hormone and 1,25(OH)2-vitamin D3 levels and
calcium excretion are assessed. Patients are randomized to precisely-
controlled constant diets, providing from 400 to 2000 mg calcium and from
10 to 300 mEq sodium/day for eight weeks, utilizing a 3 x 3 factorial
design with repeated measures. The dietary content of potassium, chloride
and magnesium are also controlled. Repeated determination of baseline
measures are performed at four and eight weeks to define both the extent
and time course of these effects and to provide insight into their
potential mechanisms.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ontogeny of calcium transport by intestinal Golgi in spontaneously hypertensive rats and genetically matched WKY rats.
自发性高血压大鼠和遗传匹配的 WKY 大鼠肠道高尔基体钙转运的个体发育。
DOI:
10.1203/00006450-199012000-00009
发表时间:
1990
期刊:
Pediatric research
影响因子:
3.6
作者:
[Shibata,H, Ghishan,FK]
通讯作者:
Ghishan,FK
Recent advances in the treatment of orthostatic hypotension.
直立性低血压治疗的最新进展。
DOI:
--
发表时间:
1995
期刊:
Neurology.
影响因子:
--
作者:
[Robertson,D, Davis,TL]
通讯作者:
Davis,TL
Caffeine and theophylline as adenosine receptor antagonists in humans.
咖啡因和茶碱作为人类腺苷受体拮抗剂。
DOI:
--
发表时间:
1991
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
[Biaggioni,I, Paul,S, Puckett,A, Arzubiaga,C]
通讯作者:
Arzubiaga,C
DOI:
--
发表时间:
1992
期刊:
American journal of hypertension
影响因子:
3.2
作者:
[Robertson,D, Mosqueda-Garcia,R, Robertson,RM, Biaggioni,I]
通讯作者:
Biaggioni,I
A Simple Liquid-ChromatographicMethodAppliedto DetermineCaffeine in Plasma and Tissues
一种简单的液相色谱法测定血浆和组织中的咖啡因
DOI:
--
发表时间:
2004
期刊:
影响因子:
--
作者:
[Biaggionl, Robertson]
通讯作者:
Robertson
共 8 条
PHARMACOLOGIC PROBES IN NEURALLY-MEDIATED SYNCOPE
-
批准号:7207209
-
项目类别:
-
资助金额:$1.7万
-
财政年份:2004
-
负责人:ROSE M ROBERTSON
-
依托单位:
Pharmacologic Probes in Neurally-Mediated Syncope
-
批准号:7041378
-
项目类别:
-
资助金额:$1.38万
-
财政年份:2003
-
负责人:ROSE M ROBERTSON
-
依托单位:
Building Interdisciplinary Research Careers in Women's *
-
批准号:6577552
-
项目类别:
-
资助金额:$48.92万
-
财政年份:2002
-
负责人:ROSE M ROBERTSON
-
依托单位:
Baroreflex failure: Mechanisms and therapy
-
批准号:6630245
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2002
-
负责人:ROSE M ROBERTSON
-
依托单位:
CORE--CLINICAL
-
批准号:6611200
-
项目类别:
-
资助金额:$11.66万
-
财政年份:2002
-
负责人:ROSE M ROBERTSON
-
依托单位:
Building Interdisciplinary Research Careers in Women's *
-
批准号:6666820
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2002
-
负责人:ROSE M ROBERTSON
-
依托单位:
CORE--CLINICAL
-
批准号:6475041
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2001
-
负责人:ROSE M ROBERTSON
-
依托单位:
CORE--CLINICAL
-
批准号:6353552
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2000
-
负责人:ROSE M ROBERTSON
-
依托单位:
PHARMACOLOGIC PROBES IN NEURALLY-MEDIATED SYNCOPE
-
批准号:6390688
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2000
-
负责人:ROSE M ROBERTSON
-
依托单位:
PHARMACOLOGIC PROBES IN NEURALLY-MEDIATED SYNCOPE
-
批准号:6087248
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2000
-
负责人:ROSE M ROBERTSON
-
依托单位:
CORE--CLINICAL
-
批准号:6202535
-
项目类别:
-
资助金额:$19.09万
-
财政年份:1999
-
负责人:ROSE M ROBERTSON
-
依托单位:
CORE--CLINICAL
-
批准号:6110737
-
项目类别:
-
资助金额:$19.09万
-
财政年份:1998
-
负责人:ROSE M ROBERTSON
-
依托单位:
CORE--CLINICAL
-
批准号:6242731
-
项目类别:
-
资助金额:$18.83万
-
财政年份:1997
-
负责人:ROSE M ROBERTSON
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF CARDIOVASCULAR DISEASES
-
批准号:2027310
-
项目类别:
-
资助金额:$32.82万
-
财政年份:1994
-
负责人:ROSE M ROBERTSON
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF CARDIOVASCULAR DISEASES
-
批准号:2656349
-
项目类别:
-
资助金额:$33.31万
-
财政年份:1994
-
负责人:ROSE M ROBERTSON
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF CARDIOVASCULAR DISEASES
-
批准号:2212301
-
项目类别:
-
资助金额:$32.18万
-
财政年份:1994
-
负责人:ROSE M ROBERTSON
-
依托单位:
PHARMACOLOGY AND PHYSIOLOGY OF CARDIOVASCULAR DISEASES
-
批准号:2212300
-
项目类别:
-
资助金额:$31.94万
-
财政年份:1994
-
负责人:ROSE M ROBERTSON
-
依托单位:
EFFECTS OF NUTRIENTS IN HYPERTENSION
-
批准号:3353945
-
项目类别:
-
资助金额:$22.63万
-
财政年份:1992
-
负责人:ROSE M ROBERTSON
-
依托单位:
CIRCULATORY CONTROL IN CHRONIC HYPOTENSIVE STATES
-
批准号:3352443
-
项目类别:
-
资助金额:$14.77万
-
财政年份:1987
-
负责人:ROSE M ROBERTSON
-
依托单位:
CIRCULATORY CONTROL IN CHRONIC HYPOTENSIVE STATES
-
批准号:3352440
-
项目类别:
-
资助金额:$15.67万
-
财政年份:1987
-
负责人:ROSE M ROBERTSON
-
依托单位:
海外基金